Research

Public proof for the blockers that keep stalling the buying decision

Use this library to see whether a recurring blocker feels close enough to inspect one blocker page, one dated update, or one specimen brief before paying.

Evaluating whether to buy?

Use one specimen and one diagnosis path. Then check fit or start the brief.

Companies

334

Current public corpus size.

Public signals

2024

Structured public-safe observations carried into the archive.

Recurring clusters

5

Internal patterns ranked before anything is written for a buyer.

Published blockers in the current corpus

4 blocker pages, one public research layer

Published blocker

Decision drift

A deal can stay active while the next owner, scope, or exit condition never becomes crisp enough to move.

Visible in 331 of 334.

Main blocker in 141 of 334.

Usually mistaken for a general market slowdown.

Read the decision drift blocker

Published blocker

Pricing ambiguity

Interpretation cost around packaging, units, and commercial boundaries keeps draining the deal before price is judged cleanly.

Visible in 276 of 334.

Main blocker in 23 of 334.

Usually mistaken for pure price sensitivity.

Read the pricing ambiguity blocker

Published blocker

Switching friction

Migration cost and workflow disruption feel bigger than the stated upside, even when the product case looks credible.

Visible in 254 of 334.

Main blocker in 56 of 334.

Usually mistaken for weak differentiation.

Read the switching friction blocker

Published blocker

Proof friction

The buyer still needs concrete proof they can check before the team gets a clean comparison at all.

Visible in 328 of 334.

Main blocker in 96 of 334.

Usually mistaken for a messaging problem.

Read the proof friction blocker

Latest dispatch

What surfaced most recently

Read the newest dispatch when you need the latest public delta, not the whole diagnosis.

Read the Apr 28, 2026 decision-drift dispatch

Published blockers

Canonical blocker pages for the problems that keep returning

Read one blocker page when you want the stable explanation behind the counts.

Browse blocker pages

Publication history

New research should add, not replace

Reviewed releases stay visible, so the proof layer can actually grow.

Boundary

Public research stops before the company-specific diagnosis

These pages are intentionally abstracted. They prove recurrence, consequence, and the cost of misreading a blocker without exposing company identities, contacts, private outreach context, or the next move that belongs in the brief.

Read the confidentiality policy